Why participate?
Identify the key studies required to advance an antibody into clinical phases while meeting regulatory expectations
Training Context:
Before obtaining authorization to test a therapeutic antibody in humans, it is essential to demonstrate product safety and control the manufacturing process to ensure quality and traceability.
Interactive Teaching, Case Studies, Experience Sharing
Project Managers, Regulatory Affairs Managers, R&D, Preclinical or Clinical Development Teams, Chief Scientific Officers
Solid knowledge in biotechnology and therapeutic antibodies, or completion of the course “Fundamentals of therapeutic antibodies”
Prices: Excluding tax, as the training is not subject to VAT.
In-house training rate: Please contact us.
There is no rating available because this training session was never carried out.
Registering online or by e-mail is a pre-registration. We will process your request within one week:
Signing the training agreement commits the company or individual to the training course. Cancellation conditions are specified in the training agreement.
When no session date is specified, pre-registration allows us to note your interest in a programme, and we will keep you informed as soon as a new session is organised.
For more information, contact Daphné Brisard: 02 47 36 63 18 or formation@mabdesign.fr
